Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

NEJM Journal Watch Nutrition/Obesity for November 27, 2023

NEJM Journal Watch | Nutrition/Obesity
November 27, 2023
Gustavo Braslavsky
This is a free email alert. To experience NEJM Journal Watch in full, please subscribe.

SUMMARY AND COMMENT  

Semaglutide in Patients with Obesity and Cardiovascular Disease — But Without Diabetes

Allan S. Brett, MD, reviewing

In such patients, weekly injections of semaglutide lowered the incidence of adverse cardiovascular events.

SUMMARY AND COMMENT  

Olanzapine Improves Weight Gain in Patients with Advanced Cancer on Chemotherapy

Elizabeth Prsic, MD, reviewing

MORE IN NUTRITION/OBESITY »

NEJM CareerCenter Jobs

Endocrinologist

Endocrinology

Somerville, Massachusetts

Endocrinologist

Endocrinology

Connecticut

Endocrinologist

Endocrinology

Grand Junction, Colorado

Endocrinologist

Endocrinology

Norwalk, Connecticut

nejmcareercenter.org

SPECIAL OFFER
Subscribe to NEJM Journal Watch General Medicine
NEJM Journal Watch General Medicine is a clinician's first source for summaries of the latest research and guidelines that affect patient care. Stay clinically prepared and foster professional development with a subscription today. For the latest medical research developments in a clinically relevant context Subscribe today.

FOLLOW US



This post first appeared on Clinical Trials News, please read the originial post: here

Share the post

NEJM Journal Watch Nutrition/Obesity for November 27, 2023

×

Subscribe to Clinical Trials News

Get updates delivered right to your inbox!

Thank you for your subscription

×